08.12.2021 17:42:18

EQS-Adhoc: Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities

EQS-Ad-hoc: Zur Rose Group AG / Key word(s): Capital Increase
Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities

08-Dec-2021 / 17:42 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Please find our press release about a capital increase under the following link:

https://zurrosegroup.com/websites/zurrosegroup/English/203015/capital-increase.html

 


End of ad hoc announcement
Language: English
Company: Zur Rose Group AG
Walzmühlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1255691

 
End of Announcement EQS News Service

1255691  08-Dec-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1255691&application_name=news&site_id=smarthouse

Analysen zu DocMorris AG (ex Zur Rose)mehr Analysen

07.02.25 DocMorris Sell UBS AG
04.02.25 DocMorris Buy Jefferies & Company Inc.
29.01.25 DocMorris Hold Warburg Research
24.01.25 DocMorris Hold Deutsche Bank AG
22.01.25 DocMorris Hold Deutsche Bank AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DocMorris AG (ex Zur Rose) 91,60 4,09% DocMorris AG (ex Zur Rose)